敲减TLR2基因对结直肠癌细胞增殖的抑制作用及其机制

doi:10.13481/j.1671-587x.20200218

摘要/Abstract

摘要： 目的：应用慢病毒RNA干扰技术敲减结直肠癌细胞中Toll样受体2（TLR2）基因，探讨其对结直肠癌细胞增殖的作用，并阐明其作用机制。方法：将处于对数生长期的结直肠癌HCT116细胞和HT29细胞分为未感染对照组、阴性对照组及基因敲减组（TLR2-RNAi组），分别给予无慢病毒感染、慢病毒RNAi及慢病毒TLR2-RNAi稳定转染。感染后采用蛋白印迹法检测各组细胞中TLR2蛋白表达水平，采用CCK-8法和流式细胞术检测各组细胞增殖活性及不同细胞周期细胞百分率，蛋白印迹法检测各组细胞中磷脂酰肌醇3-激酶/蛋白激酶（PI3K/Akt）和核因子κB（NF-κB）细胞信号通路相关蛋白及细胞周期相关蛋白cyclin D1、cyclin D3蛋白表达水平。结果：与未感染对照组和阴性对照组比较，TLR2-RNAi组HCT116细胞和HT29细胞中TLR2蛋白表达水平明显降低（P<0.01）。与未感染对照组和阴性对照组比较，TLR2-RNAi组HCT116细胞和HT29细胞增殖活性明显降低（P<0.05），S期和G₂期细胞百分率明显降低（P<0.05），G₁期细胞百分率明显升高（P<0.05）。与未感染对照组和阴性对照组比较，TLR2-RNAi组HCT116细胞和HT29细胞中PI3K、p-Akt、p-NF-κβ、cyclin D1和cyclin D3蛋白表达水平明显降低（P<0.01）。结论：敲减TLR2基因可以通过调控PI3K/Akt和NF-κB细胞信号通路及细胞周期相关蛋白cyclin D1和cyclin D3的表达而抑制结直肠癌细胞的增殖。

关键词: 结直肠肿瘤, Toll样受体2基因, 细胞增殖, 细胞周期

Abstract: Objective: To knock down the Toll-like receptor 2 (TLR2) gene in the colorectal cancer cells with lentiviral RNA interference technology, to explore its effect on the colorectal cancer cell proliferation, and to clarify its mechanism. Methods: The colorectal cancer HCT116 cells and HT29 cells in logarithmic phase were divided into non-infection control group, negative control group and gene knockdown group(TLR2-RNAi group); the cells were transfected with lentivirus-free, lentivirus-RNAi and lentivirus-TLR2-RNAi, respectively. The expression levels of TLR2 protein in the cells in various groups were detected by Western blotting method after stable transfection.The cell proliferation activities and the percentages of cells in different cell cycles were detected by CCK-8 method and flow cytometry. Western blotting method was used to detect the expression levels of PI3K/Akt and nuclear factor-κB(NF-κB) signaling pathway-related proteins and cell cycle-associated proteins cyclin D1 and cyclin D3 proteins in the cells in various groups. Results: Compared with non-infection control group and negative control group, the expression levels of TLR2 protein in the HCT116 cells and the HT29 cells in TLR2-RNAi group were decreased significantly (P<0.01). Compared with non-infection control group and negative control group,the cell proliferation activities in the HCT116 cells and the HT29 cells in TLR2-RNAi group were significantly decreased (P<0.05); the percentages of cells in S phase and G₂ phase were decreased significantly (P<0.05), and the percentages of cells in G₁ phase were increased significantly (P<0.05). Compared with non-infection control group and negative control group, the expression levels of PI3K, p-Akt, p-NF-κB, cyclin D1 and cyclin D3 proteins in the HCT116 cells and HT29 cells in TLR2-RNAi group were significantly decreased(P<0.01). Conclusion: Knockdown of TLR2 gene can inhibit the proliferation of colorectal cancer cells by regulating the expressions of PI3K/Akt and NF-κB cell signaling pathway proteins and cell cycle-associated proteins.

Key words: colorectal neoplasms, Toll-like receptor-2 gene, cell proliferation, cell cycle

中图分类号:

R735.3

孟爽, 李迎杰, 臧晓珍, 赵乾芳, 张进, 李静. 敲减TLR2基因对结直肠癌细胞增殖的抑制作用及其机制[J]. 吉林大学学报(医学版), 2020, 46(02): 316-322.

MENG Shuang, LI Yingjie, ZANG Xiaozhen, ZHAO Qianfang, ZHANG Jin, LI Jing. Inhibitory effect of knockdown of TLR2 gene on proliferation of colorectal cancer cells and its mechanism[J]. Journal of Jilin University(Medicine Edition), 2020, 46(02): 316-322.

参考文献

[1] ARNOLD M, SIERRA M S,LAVERSANNE M, et al. Global patterns and trends in colorectal cancer incidence and mortality[J].Gut,2017,66:683-691.
[2] SCHREUDERS E H, RUCO A, RABENECK L,et al. Colorectal cancer screening:a global overview of existing programmes[J]. Gut, 2015, 64(10):1637-1649.
[3] LINNEKAMP J F,WANG X, MEDEMA J P,et al.Colorectal cancer heterogeneity and targeted therapy:a case for molecular disease subtypes[J]. Cancer Res, 2015,75(2):245-249.
[4] LIU Y, YIN H, ZHAO M, et al. TLR2 and TLR4 in autoimmune diseases:a comprehensive review[J]. Clin Rev Allergy Immunol, 2014, 47(2):136-147.
[5] LIU Y D, JI C B, LI S B, et al. Toll-like receptor 2 stimulation promotes colorectal cancer cell growth via PI3K/Akt and NF-κB signaling pathways[J]. Int Immunopharmacol, 2018, 9:375-383.
[6] LU C C, KUO H C, WANG F S, et al. Upregulation of TLRs and IL-6 as a marker in human colorectal cancer[J]. Int J Mol Sci, 2015, 16(1):159-177.
[7] MEDVEDEV A E. Toll-like receptor polymorphisms, inflammatory and infectious diseases, allergies, and cancer[J]. J Interferon Cytokine Res, 2013,33(9):467-484.
[8] HERNANDEZ C, HUEBENER P, SCHWABE R F. Damage-associated molecular patterns in cancer:a double-edged sword[J]. Oncogene, 2016, 35(46):5931-5941.
[9] PROENCA M A, DE OLIVEIRA J G, CADAMURO A C, et al. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer[J]. World J Gastroenterol, 2015, 21(25):7730-7741.
[10] KENNEDY C L, NAJDOVSKA M, TYE H, et al. Differential role of MyD88 and Mal/TIRAP in TLR2-mediated gastric tumourigenesis[J]. Oncogenes, 2014, 33(19):2540-2546.
[11] WEST A C, TANG K,TYE H, et al. Identification of a TLR2-regulated gene signature associated with tumor cell growth in gastric cancer[J]. Oncogenes, 2017, 36(36):5134-5144.
[12] GRIMMIG T, MOENCH R, KRECKEL J, et al. Toll like receptor 2, 4, and 9 signaling promotes autoregulative tumor cell growth and VEGF/PDGF expression in human pancreatic cancer[J]. Int J Mol Sci, 2016, 17(12):e2060.
[13] SCHEEREN F A, KUO A H, et al. A cell-intrinsic role for TLR2-MYD88 in intestinal and breast epithelia and oncogenesis[J]. Nat Cell Biol, 2014, 16(12):1238-1248.
[14] MASTORCI K, MURARARO E, PASINI E, et al. Toll-like receptor 1/2 and 5 ligands enhance the expression of cyclin D1 and D3 and induce proliferation in mantle cell lymphoma[J]. PLoS One, 2016, 11(4):e0153823.
[15] LI X T, QIAN D M, JU F, et al. Upregulation of Toll-like receptor 2 expression in colorectal cancer infected by human cytomegalovirus[J]. Oncol Lett, 2015, 9(1):365-370.
[16] GUO H, CHEN Y, HU X, et al.The regulation of Toll-like receptor 2 by miR-143 suppresses the invasion and migration of a subset of human colorectal carcinoma cells[J]. Mol Cancer, 2013, 12:77.
[17] WANG M J, PING J,LI Y, et al. Prognostic significance and molecular features of colorectal mucinous adenocarcinomas:a strobe-compliant study[J]. Medicine (Baltimore), 2015,94(51):e2350.
[18] SEMLALI A, REDDY P N, ARAFAH M, et al. Expression and polymorphism of Toll-like receptor 4 and effect on NF-κB mediated inflammation in colon cancer patients[J]. PLoS One, 2016,11(1):e0146333.
[19] GUTTRIDGE D C, ALBANESE C, REUTHER J Y, et al. NF-kappaB controls cell growth and differentiation through transcriptional regulation of cyclin D1[J]. Mol Cell Biol, 1999, 19(8):5785-5799.
[20] WILLIAMS G H, STOECER K. The cell cycle and cancer[J]. J Pathol, 2012, 226(2):352-364.
[21] LIU Y Y, FAN C H, PU L, et al. Phloretin induces cell cycle arrest and apoptosis of human glioblastoma cells through the generation of reactive oxygen species[J]. J Neurooncol,2016,128(2):217-223.